home / stock / crmd / crmd news


CRMD News and Press, CorMedix Inc. From 02/28/22

Stock Information

Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com

Menu

CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...

CRMD - IntriCon, NeuroSense top healthcare gainers; Aurinia, Lexicon lead losers' pack

Gainers: IntriCon (NASDAQ:IIN) +37%. NeuroSense Therapeutics (NASDAQ:NRSN) +28%. Homology Medicines (NASDAQ:FIXX) +17%. CorMedix (NASDAQ:CRMD) +14%. Reata Pharmaceuticals (NASDAQ:RETA) +13%. Losers: Aurinia Pharmaceuticals (NASDAQ:AUPH) -29%. Lexicon Pharmac...

CRMD - Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath

BERKELEY HEIGHTS, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has resubmitted...

CRMD - CorMedix to Participate in Upcoming January Conferences

BERKELEY HEIGHTS, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix managemen...

CRMD - CorMedix Inc Common Stock (CRMD) Q3 2021 Earnings Call Transcript

Image source: The Motley Fool. CorMedix Inc Common Stock (NASDAQ: CRMD) Q3 2021 Earnings Call Nov 09, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: CorMedix Inc Common Stock (CRMD) Q3 2021 Earnings Call Transcript...

CRMD - CorMedix Inc. (CRMD) CEO Matt David on Q3 2021 Earnings Call Transcript

CorMedix Inc. (CRMD) Q3 2021 Earnings Conference Call Nov 09, 2021 04:30 PM AM ET Company Participants Dan Ferry - LifeSci Advisors, IR Matt David - Interim CEO, EVP, and CFO Phoebe Mounts - EVP and General Counsel Conference Call Participants Jason Butler - JMP Securities Rohit Bhasin - Need...

CRMD - CorMedix EPS misses by $0.04, beats on revenue

CorMedix (NASDAQ:CRMD): Q3 GAAP EPS of -$0.22 misses by $0.04. Revenue of $0.04M (-55.6% Y/Y) beats by $0.04M. Press Release Total cash on hand and short-term investments as of September 30, 2021 was $72.0M, excluding restricted cash of $0.2M. The Company believes that, based on the Company&#...

CRMD - CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for t...

CRMD - CCNC, WIMI and SBEA among pre market gainers

Baosheng Media Group (NASDAQ:BAOS) +84%. Bone Biologics (OTCPK:BBLG) +36%. Nxt-ID (NASDAQ:NXTD) +34%. SilverBox Engaged Merger (NASDAQ:SBEA) +29% issues letter to investors and partners regarding proposed combination with Black Rifle coffee company Arista Networks ANET +19% add...

CRMD - CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9

BERKELEY HEIGHTS, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its...

CRMD - OCGN, MVST and ACHR among pre market gainers

ABVC BioPharma ABVC +233% amid social media buzz Golden Star Resources GSS +18% Chifeng Jilong Gold to buy Golden Star Resources in $470M deal ANI Pharmaceuticals ANIP +15% on Q3 earnings. Archer Aviation (NYSE:ACHR) +11%. DBV Technologies (NASDAQ:DBVT) +13% to h...

Previous 10 Next 10